Article
EGFR mutations and ROS1 and ALK rearrangements in a large series of non-small cell lung cancer in South India.
Cancer reports (Hoboken, N.J.) - 1 Dec 2020
Tarigopula Anil, Ramasubban Gayathri, Chandrashekar Vani, Govindasami Perumal, Chandran Chitra
Abstract excerpt
BACKGROUND: Driver mutations are seen in 80% of lung adenocarcinomas, and they influence prognosis and choice of therapy. AIM: Aim of this study was to analyse the frequency of epidermal growth factor receptor (EGFR) mutations, ALK and ROS1 rearrangements and their association with age and gender in non-small cell lung cancer reported from a tertiary care center in South India. METHODS: Tumors from patients with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
